Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04708340
Status:
UNKNOWN
Last Update Posted:
2022-03-15
First Post:
2021-01-04
Brief Title:
Tolerability and Efficacy of RJX in Patients With COVID-19
Sponsor:
Reven Pharmaceuticals Inc
Organization:
Reven Pharmaceuticals Inc
Organization Data
Organization:
Reven Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
RPI015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Reven Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None